COVID-19 vaccine race: Main candidates and where they stand

Co-developed by the University of Oxford and British-Swedish company AstraZeneca and known as Covishield in India, the vaccine was the first on which a scientific study was published based on Phase 3 clinical trials.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39aTbVO
via IFTTT